LG 101506: High-Purity RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a small molecule RXR modulator with ≥98% purity, designed for in vitro research on RXR signaling (APExBIO). It exhibits high solubility (42.05 mg/ml in DMSO, 21.03 mg/ml in ethanol) under controlled conditions (off-white solid, -20°C storage). RXR modulation is critical for dissecting metabolism regulation, nuclear receptor biology, and immune checkpoint pathways in disease models (Zhang et al., 2022). LG 101506 is not intended for diagnostic or clinical use. Documentation and shipping protocols ensure compound stability and reproducibility in experimental settings (APExBIO, 2024).

Biological Rationale

Retinoid X Receptor (RXR) is a nuclear receptor that heterodimerizes with other receptors to regulate gene expression in metabolic, developmental, and immunological contexts (Zhang et al., 2022). RXR pathways influence transcriptional networks controlling lipid metabolism, glucose homeostasis, and immune cell differentiation. In oncology, RXR signaling modulates tumor cell plasticity and immune evasion, notably through crosstalk with immune checkpoint regulators such as PD-L1. The ability to modulate RXR activity with specific ligands, such as LG 101506, provides a mechanistic tool for elucidating nuclear receptor functions in both health and disease. RXR modulation is especially relevant in immune-cold tumors, where it can help uncover new therapeutic strategies (see contrast: This article updates the mechanistic focus by connecting RXR modulation to immune checkpoint biology in cancer models).

Mechanism of Action of LG 101506

LG 101506 ((2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid) is a small molecule ligand that binds and modulates RXR activity. By allosterically altering RXR conformation, LG 101506 influences the recruitment of co-regulators and the transcriptional output of RXR target genes. This modulation can affect heterodimerization with other nuclear receptors (e.g., PPAR, LXR, FXR), shifting downstream gene expression patterns relevant to cellular metabolism, immune response, and tumor biology (see contrast: Here, we detail the explicit chemical mechanism and solubility benchmarks not covered in the referenced summary). The compound’s robust solubility in DMSO and ethanol allows for flexible dosing and experimental paradigms.

Evidence & Benchmarks

• LG 101506 is reported at ≥98% purity and a molecular weight of 420.53 g/mol under standard laboratory conditions (APExBIO product page).
• The compound is soluble to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol (ambient temperature, APExBIO).
• RXR modulation is pivotal for regulating nuclear receptor signaling in metabolism and immune evasion models (Zhang et al., 2022).
• Loss of RXR pathway components can influence PD-L1 glycosylation and immune checkpoint efficacy in triple-negative breast cancer (Zhang et al., 2022).
• LG 101506’s stability is maintained with blue or dry ice shipment and -20°C storage, supporting reproducibility in research workflows (APExBIO).

Applications, Limits & Misconceptions

LG 101506 is used in RXR signaling pathway research, especially in cellular and biochemical studies exploring nuclear receptor roles in metabolism, immune regulation, and disease modeling. Its role as a small molecule RXR modulator makes it valuable for dissecting RXR-driven gene networks, testing RXR/partner receptor interactions, and evaluating the impact on immune checkpoint biology in cancer models (see contrast: This article extends prior coverage by emphasizing practical workflow integration and validated purity benchmarks).

Common Pitfalls or Misconceptions

• LG 101506 is not suitable for diagnostic or therapeutic applications; it is for research use only (APExBIO).
• Long-term storage of prepared solutions is discouraged due to potential degradation; use solutions promptly after preparation (APExBIO, 2024).
• The compound does not directly inhibit or activate immune checkpoints; its action is limited to RXR pathway modulation.
• Experimental results may vary depending on cell type, buffer composition, and assay conditions; always validate under your specific protocol.
• Not all nuclear receptor-related pathways are equally responsive to RXR modulation; context and receptor pairing are critical.

Workflow Integration & Parameters

For optimal use, LG 101506 should be stored at -20°C and protected from light and moisture. Solutions should be prepared fresh, with 42.05 mg/ml solubility in DMSO and 21.03 mg/ml in ethanol. Shipping with blue or dry ice preserves compound integrity. Researchers are advised to use validated controls and replicate experiments for robust results. LG 101506 is compatible with various in vitro RXR-binding, gene reporter, and metabolic assays (APExBIO).

Conclusion & Outlook

LG 101506, as offered by APExBIO, is a rigorously benchmarked RXR modulator supporting advanced research into nuclear receptor signaling and metabolic regulation (LG 101506). Its high purity and solubility profile make it a preferred tool for dissecting RXR biology, especially in immune-cold cancer models where RXR-mediated pathways interact with immune checkpoints (Zhang et al., 2022). For expanded mechanistic and workflow-focused perspectives, see LG 101506: Unraveling RXR Modulation in Cancer Immunity R... (which this article supplements by adding explicit evidence and storage guidelines).